{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T23:50:22Z","timestamp":1773705022680,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.jconrel.2023.08.051","type":"journal-article","created":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T12:22:26Z","timestamp":1693484546000},"page":"197-209","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["PEG2000-PLA-based nanoscale polymeric micelles reduce paclitaxel-related toxicity in beagle dogs"],"prefix":"10.1016","volume":"362","author":[{"given":"Jun","family":"Lu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benkun","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minjuan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fangfei","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuqing","family":"Lou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianqing","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingsong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baohui","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2023.08.051_bb0005","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.annonc.2020.10.479","article-title":"Comparing nanoparticle polymeric micellar paclitaxel and solvent-based paclitaxel as first-line treatment of advanced non-small-cell lung cancer: an open-label, randomized, multicenter, phase III trial","volume":"32","author":"Shi","year":"2021","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jconrel.2023.08.051_bb0010","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/s41565-019-0567-y","article-title":"Smart cancer nanomedicine","volume":"14","author":"van der Meel","year":"2019","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2023.08.051_bb0015","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jconrel.2022.03.055","article-title":"Critical clinical gaps in cancer precision nanomedicine development","volume":"345","author":"Gan","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.08.051_bb0020","series-title":"Basic & Clinical Pharmacology","author":"Katzung","year":"2004"},{"key":"10.1016\/j.jconrel.2023.08.051_bb0025","series-title":"Principles of Clinical Pharmacology","author":"Huang","year":"2012"},{"key":"10.1016\/j.jconrel.2023.08.051_bb0030","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1248\/bpb.b12-01102","article-title":"Clinical application of drug delivery systems in cancer chemotherapy: review of the efficacy and side effects of approved drugs","volume":"36","author":"Iwamoto","year":"2013","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.jconrel.2023.08.051_bb0035","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/cpt.603","article-title":"Drug-induced ototoxicity: mechanisms, pharmacogenetics, and protective strategies","volume":"101","author":"Lanvers-Kaminsky","year":"2017","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2023.08.051_bb0040","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/nrd1720","article-title":"Elucidating mechanisms of drug-induced toxicity","volume":"4","author":"Liebler","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2023.08.051_bb0045","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nrclinonc.2015.222","article-title":"Patient-reported outcomes in the evaluation of toxicity of anticancer treatments","volume":"13","author":"Di Maio","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2023.08.051_bb0050","doi-asserted-by":"crossref","first-page":"816","DOI":"10.20892\/j.issn.2095-3941.2020.0212","article-title":"Equivalent efficacy study of QL1101 and bevacizumab on untreated advanced non-squamous non-small cell lung cancer patients: a phase 3 randomized, double-blind clinical trial","volume":"18","author":"Chu","year":"2021","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.jconrel.2023.08.051_bb0055","doi-asserted-by":"crossref","first-page":"28","DOI":"10.21147\/j.issn.1000-9604.2022.01.03","article-title":"Equivalent efficacy assessment of QL1101 and bevacizumab in nonsquamous non-small cell lung cancer patients: a two-year follow-up data update","volume":"34","author":"Lu","year":"2022","journal-title":"Chin. J. Cancer Res."},{"key":"10.1016\/j.jconrel.2023.08.051_bb0060","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.3390\/cancers12061609","article-title":"Nanomedicine in non-small cell lung cancer: from conventional treatments to immunotherapy","volume":"12","author":"Garcia-Fernandez","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jconrel.2023.08.051_bb0065","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10637-017-0506-4","article-title":"Phase I dose escalation and pharmacokinetic study on the nanoparticle formulation of polymeric micellar paclitaxel for injection in patients with advanced solid malignancies","volume":"36","author":"Shi","year":"2018","journal-title":"Investig. New Drugs"},{"key":"10.1016\/j.jconrel.2023.08.051_bb0070","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1039\/C8CS00022K","article-title":"Computational studies of micellar and nanoparticle nanomedicines","volume":"47","author":"Sen","year":"2018","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jconrel.2023.08.051_bb0075","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.addr.2020.09.009","article-title":"Polymeric micelles for the delivery of poorly soluble drugs: from nanoformulation to clinical approval","volume":"156","author":"Hwang","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2023.08.051_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121961","article-title":"Polymeric micellar paclitaxel (pm-Pac) prolonged overall survival for NSCLC patients without pleural metastasis","volume":"623","author":"Lu","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2023.08.051_bb0085","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2147\/IJN.S372961","article-title":"Paclitaxel has a reduced toxicity profile in healthy rats after polymeric micellar nanoparticle delivery","volume":"18","author":"Lu","year":"2023","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2023.08.051_bb0090","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1517\/14740338.6.5.609","article-title":"Paclitaxel: a review of adverse toxicities and novel delivery strategies","volume":"6","author":"Marupudi","year":"2007","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.jconrel.2023.08.051_bb0095","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1080\/17425255.2021.1943358","article-title":"Current opinion on the pharmacogenomics of paclitaxel-induced toxicity","volume":"17","author":"Al-Mahayri","year":"2021","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.jconrel.2023.08.051_bb0100","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41573-018-0006-z","article-title":"Delivery technologies for cancer immunotherapy","volume":"18","author":"Riley","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2023.08.051_bb0105","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s40364-022-00400-5","article-title":"Blood-based tumour mutation index act as prognostic predictor for immunotherapy and chemotherapy in non-small cell lung cancer patients","volume":"10","author":"Lu","year":"2022","journal-title":"Biomark Res."},{"key":"10.1016\/j.jconrel.2023.08.051_bb0110","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.723670","article-title":"ctDNA-profiling-based UBL biological process mutation status as a predictor of Atezolizumab response among TP53-negative NSCLC patients","volume":"12","author":"Lu","year":"2021","journal-title":"Front. Genet."},{"key":"10.1016\/j.jconrel.2023.08.051_bb0115","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.732125","article-title":"TP53 mutation status and biopsy lesion type determine the immunotherapeutic stratification in non-small-cell lung Cancer","volume":"12","author":"Lu","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2023.08.051_bb0120","doi-asserted-by":"crossref","first-page":"i20","DOI":"10.1093\/annonc\/mdx704","article-title":"Osimertinib and other third-generation EGFR TKI in EGFR-mutant NSCLC patients","volume":"29","author":"Remon","year":"2018","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jconrel.2023.08.051_bb0125","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1001\/jamaoncol.2018.3039","article-title":"Effect of Anlotinib as a third-line or further treatment on overall survival of patients with advanced non-small cell lung Cancer: the ALTER 0303 phase 3 randomized clinical trial","volume":"4","author":"Han","year":"2018","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.jconrel.2023.08.051_bb0130","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202101658R","article-title":"Screening anlotinib responders via blood-based proteomics in non-small cell lung cancer","volume":"36","author":"Lu","year":"2022","journal-title":"FASEB J."},{"key":"10.1016\/j.jconrel.2023.08.051_bb0135","doi-asserted-by":"crossref","first-page":"1801562","DOI":"10.1183\/13993003.01562-2018","article-title":"Role of anlotinib-induced CCL2 decrease in anti-angiogenesis and response prediction for nonsmall cell lung cancer therapy","volume":"53","author":"Lu","year":"2019","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jconrel.2023.08.051_bb0140","first-page":"1900721","article-title":"Circulating DNA-based sequencing guided Anlotinib therapy in non-small cell lung Cancer","volume":"6","author":"Lu","year":"2019","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.jconrel.2023.08.051_bb0145","doi-asserted-by":"crossref","first-page":"7794","DOI":"10.1200\/JCO.2005.04.937","article-title":"Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer","volume":"23","author":"Gradishar","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2023.08.051_bb0150","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nrc.2016.108","article-title":"Cancer nanomedicine: progress, challenges and opportunities","volume":"17","author":"Shi","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2023.08.051_bb0155","doi-asserted-by":"crossref","first-page":"6370","DOI":"10.7150\/thno.57828","article-title":"Recent progress in nanomedicine for enhanced cancer chemotherapy","volume":"11","author":"Wei","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2023.08.051_bb0160","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.actbio.2020.12.009","article-title":"Clinical applications of nanomedicines in lung cancer treatment","volume":"121","author":"Norouzi","year":"2021","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2023.08.051_bb0165","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1056\/NEJMra1515442","article-title":"Antiemetic prophylaxis for chemotherapy-induced nausea and vomiting","volume":"374","author":"Navari","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2023.08.051_bb0170","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1016\/j.jaad.2011.02.026","article-title":"Chemotherapy-induced alopecia","volume":"67","author":"Chon","year":"2012","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jconrel.2023.08.051_bb0175","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.3390\/curroncol28040273","article-title":"Chemotherapy-induced neuropathy and diabetes: a scoping review","volume":"28","author":"Sempere-Bigorra","year":"2021","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.jconrel.2023.08.051_bb0180","first-page":"586","article-title":"Chemotherapy-induced cardiovascular toxicity: beyond anthracyclines","volume":"80","author":"Ai","year":"2014","journal-title":"Minerva Anestesiol."},{"key":"10.1016\/j.jconrel.2023.08.051_bb0185","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1093\/ajhp\/59.suppl_4.S4","article-title":"Chemotherapy-associated hematopoietic toxicity","volume":"59","author":"Kuhn","year":"2002","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/j.jconrel.2023.08.051_bb0190","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1023\/A:1023565227808","article-title":"Toxicity patterns of cytotoxic drugs","volume":"21","author":"Chatelut","year":"2003","journal-title":"Investig. New Drugs"},{"key":"10.1016\/j.jconrel.2023.08.051_bb0195","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.835616","article-title":"Ayurveda-based botanicals as therapeutic adjuvants in paclitaxel-induced myelosuppression","volume":"13","author":"Saggam","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jconrel.2023.08.051_bb0200","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1200\/JCO.1996.14.11.2923","article-title":"Evaluation of long-term toxicity after chemotherapy for testicular cancer","volume":"14","author":"Bokemeyer","year":"1996","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2023.08.051_bb0205","doi-asserted-by":"crossref","first-page":"5374","DOI":"10.1200\/JCO.2007.11.2243","article-title":"Long-term toxicity monitoring via electronic patient-reported outcomes in patients receiving chemotherapy","volume":"25","author":"Basch","year":"2007","journal-title":"J. Clin. Oncol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365923005515?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365923005515?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:47:28Z","timestamp":1759164448000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365923005515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":41,"alternative-id":["S0168365923005515"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2023.08.051","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PEG2000-PLA-based nanoscale polymeric micelles reduce paclitaxel-related toxicity in beagle dogs","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2023.08.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}